Bristol-Myers Squibb
BMY
#173
Rank
NZ$222.14 B
Marketcap
NZ$108.75
Share price
0.53%
Change (1 day)
39.57%
Change (1 year)

Bristol-Myers Squibb (BMY) - Net assets

Net assets on the balance sheet as of June 2026 : NZ$39.69 Billion

According to Bristol-Myers Squibb's latest financial reports the company has NZ$39.69 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Bristol-Myers Squibb - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$31.95 B9.96%
2024-12-31$NZ$29.05 B-37.68%
2023-12-31$NZ$46.62 B-4.87%
2022-12-31$NZ$49.01 B-7.02%
2021-12-31$NZ$52.71 B0.4%
2020-12-31$NZ$52.50 B-31.61%
2019-12-31$NZ$76.76 B264.48%
2018-12-31$NZ$21.06 B26.26%
2017-12-31$NZ$16.68 B-29.32%
2016-12-31$NZ$23.59 B11.98%
2015-12-31$NZ$21.07 B10.21%
2014-12-31$NZ$19.12 B3.14%
2013-12-31$NZ$18.54 B11.84%
2012-12-31$NZ$16.57 B-18.46%
2011-12-31$NZ$20.33 B0.3%
2010-12-31$NZ$20.26 B-0.42%
2009-12-31$NZ$20.35 B-3.24%
2008-12-31$NZ$21.03 B52.57%
2007-12-31$NZ$13.78 B-2.77%
2006-12-31$NZ$14.18 B-13.52%
2005-12-31$NZ$16.39 B14.69%
2004-12-31$NZ$14.29 B-5.03%
2003-12-31$NZ$15.05 B-10.02%
2002-12-31$NZ$16.73 B-23.44%
2001-12-31$NZ$21.85 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$151.11 B 280.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$74.59 B 87.94%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$152.03 B 283.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-NZ$10.48 Billion-126.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$60.25 B 51.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.78 B-47.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$141.20 B 255.75%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$33.51 B-15.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$74.66 B 88.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$89.57 B 125.68%๐Ÿ‡ฌ๐Ÿ‡ง UK